SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,393.18 294.94
(0.60%)

Dow Jones

6,933.34 36.72
(0.53%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.49 0.49
(0.54%)

EUR-INR

107.13 0.65
(0.61%)

GBP-INR

122.87 0.50
(0.41%)

JPY-INR

0.58 0.00
(0.49%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

15424.22

EPS(TTM)

Face Value()

Div & Yield %

0.52

Back

Renaissance Global consolidated net profit rises 72.61% in the September 2025 quarter

Nov 14,2025

Net profit of Renaissance Global rose 72.61% to Rs 19.28 crore in the quarter ended September 2025 as against Rs 11.17 crore during the previous quarter ended September 2024. Sales rose 32.74% to Rs 546.36 crore in the quarter ended September 2025 as against Rs 411.60 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	546.36	411.60	33
OPM %	7.44	8.19	-
PBDT	31.77	21.44	48
PBT	23.70	14.05	69
NP	19.28	11.17	73

81,537.70 -769.67 ( -0.94%)

49,393.18 294.94 (0.60%)

6,933.34 36.72 (0.53%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.49 0.49 (0.54%)

107.13 0.65 (0.61%)

122.87 0.50 (0.41%)

0.58 0.00 (0.49%)